Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Acasti Pharma
Acasti Pharma
(ACST)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Microcrystalline cellulose
non-hodgkin lymphoma
,
lymphoma
,
vascular diseases
,
peripheral arterial disease
,
atherosclerosis
,
hypoxia
,
intermittent claudication
,
peripheral vascular diseases
,
bcr-abl positive chronic myelogenous leukemia
,
anemia
,
aplastic anemia
,
prolymphocytic leukemia t-cell
,
prolymphocytic leukemia
,
cardiovascular diseases
,
stem cell transplantation
,
syndrome
,
myelodysplastic syndromes
,
myeloid leukemia acute
,
myeloid leukemia
,
preleukemia
,
osteoarthritis
,
chronic kidney failure
,
renal insufficiency
,
prostatic neoplasms
,
knee osteoarthritis
,
thrombotic thrombocytopenic purpura
,
thrombocytopenic purpura
,
purpura
,
mucopolysaccharidoses
,
mucopolysaccharidosis i
,
musculoskeletal diseases
,
hyperparathyroidism
,
secondary hyperparathyroidism
,
lung neoplasms
,
small cell lung carcinoma
,
leukemia
,
type 2 diabetes mellitus
,
chronic renal insufficiency
,
kidney diseases
,
diabetes mellitus
,
b-cell chronic lymphocytic leukemia
,
lymphoid leukemia
,
acne vulgaris
,
multiple sclerosis
,
relapsing-remitting multiple sclerosis
,
sclerosis
,
thrombocytopenia
,
vascular calcification
,
b-cell leukemia
,
hip osteoarthritis
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use